Page last updated: 2024-08-24

irinotecan and dofequidar

irinotecan has been researched along with dofequidar in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fujita, N; Katayama, R; Koike, S; Sato, S; Sugimoto, Y; Tsuruo, T	1

Other Studies

1 other study(ies) available for irinotecan and dofequidar

Article	Year
Dofequidar fumarate sensitizes cancer stem-like side population cells to chemotherapeutic drugs by inhibiting ABCG2/BCRP-mediated drug export. Cancer science, 2009, Volume: 100, Issue:11 Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Camptothecin; Cell Line, Tumor; Female; Humans; Irinotecan; Methotrexate; Mice; Mice, Inbred BALB C; Neoplasm Proteins; Neoplastic Stem Cells; Quinolines	2009

Article

Year

Dofequidar fumarate sensitizes cancer stem-like side population cells to chemotherapeutic drugs by inhibiting ABCG2/BCRP-mediated drug export.

Cancer science, 2009, Volume: 100, Issue:11

Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Camptothecin; Cell Line, Tumor; Female; Humans; Irinotecan; Methotrexate; Mice; Mice, Inbred BALB C; Neoplasm Proteins; Neoplastic Stem Cells; Quinolines

2009